Aarhus Institute of Advanced Studies at Aarhus University offers a number of visiting fellowships to outstanding researchers from abroad who are looking for an opportunity to engage in the international and interdisciplinary research community of AIAS and to collaborate with the research environments at Aarhus University (AU).

Visiting fellows will have their daily office space at AIAS, and will have the opportunity to participate in the activities at AIAS and at the relevant research environments at AU. AIAS offers optimal office facilities, and a thriving international and interdisciplinary community with joint social and academic activities.

Application deadlines vary according to start date:

• May 1, 2025 (noon): for visiting fellowships starting in the fall of 2025.
• November 1, 2025 (noon): for visiting fellowships starting in the spring of 2026.

https://aias.au.dk/opportunities-at-aias/aias-visiting-fellowships

The canSERV Consortium is pleased to launch its Specific Call for Service Provision for early career scientists “Training the Next Generation of Cancer Researchers”. Early Career Cancer Researchers, for example first-stage researchers (PhD students, junior researchers without PhD), or recognised researchers (postdocs, assistant professors, young investigators) world-wide are invited to apply for free access to cutting-edge transnational services with an indicative overall budget for this call of EUR 500.000. The primary objective of this call is to empower early career scientists through access to research services and training in order to advance their scientific merits and careers.

Submission Deadline: 17 December 2024, 2pm CET

https://www.canserv.eu/calls/challenge-call-training-the-next-generation-of-cancer-researchers/

The Norwegian Cancer Society’s (NCS) aim is to prevent and fight cancer, and to ensure the best quality of life for patients and their families. Through research, prevention, information, support, advice, and lobbying, we fight cancer locally, nationally and globally. The NCS provides a considerable amount of all direct funding for cancer research in Norway, thus contributing to promoting a research environment of top international standard in the country. Furthermore, nurturing innovation and promoting novel ideas play a crucial role in advancing cancer research and enhancing patient outcomes.

Research findings frequently serve as the foundation for multiple potential commercial applications. In a qualification project, the primary objective is to thoroughly explore and pinpoint the most promising commercial application prospects, including service innovation. This initial investigation lays the groundwork for subsequent technology verification and development. Promising research and innovative solutions often take too long to reach patients. The NCS aims to accelerate this process, particularly for those applications with high patient benefit. This call focus on increasing the innovation potential of projects funded by the NCS (from 2016-2023).

https://nettsoknad.kreftforeningen.no/#call/1622/details

> Grant round now open – submit your application today

Grant application timeline

• Call opens: 9 September 2024
• Deadline for outline of applications: 17:00 GMT on 30 October 2024
• Full application for shortlisted applicants opens: February 2025 (date to be confirmed)
• Deadline for full applications: March 2025 (date to be confirmed)
• Funding decisions announced: September 2025

For more information

Barnekreftforeningen har siden 2017 bevilget rundt 200 millioner kroner til barnekreftforskning. Størsteparten av midlene har gått til grunnforskning på barnekreft. Takket være våre givere, kan vi også i 2024 lyse ut inntil 25 millioner kroner til denne forskningen.

Barnekreftforeningens mål er at ingen barn skal dø av kreft. Derfor må vi fortsette å forske på barnekreft.

Flere opplysninger om utlysningen finner du i søknadsportalen nedenfor (tilgjengelig fra 1. september 2024). Vilkår for å søke midler finner du her.

Søknadsfrist: 1. november 2024 kl. 12.00.

https://www.barnekreftforeningen.no/forskning/forskningss%C3%B8knader

Fullbright Norge har lyst ut stipend for det akademiske året 2025/26. Det er stipend i alle fagfelt.

Ein kan søke om stipend både som student på master og ph.d.-nivå, og som postdoc/seniorforskar.

Frist for å søke stipend er 1. oktober 2024.

Søknadsskjema finn de her:

• studenter på master- og ph.d.-nivå
• post-doc og seniorforskere

https://utdanning.no/tema/utdanning_i_utlandet/fulbrightstipendet

The World Cancer Research Fund International calls for funding on the role of diet, nutrition and physical activity in either Cancer Prevention or Cancer Survivorship. Note: these grants do not pay the salary of the PI, do not cover institutional overhead, do not fund research on anti-cancer drugs or cancer treatment. International collaboration is encouraged, but not required. There are two types of grants:

– Investigator Initiated Grants 500 GBP (7 MNOK NOK), 4 years.
– Pilot and Feasibility Grants 60 GBP (850 000 NOK), 2 years.

Deadline for outline of application: 30 October 2024 

Contact the research advisers at the Faculty and register if you plan to apply: https://www.uib.no/en/med/112772/external-funding-opportunities

5. desember deles Helseprisen ut for niende gang. Og nå kan ditt favorittprosjekt være med i jakten på den gjeve prisen.

   Hele 50.000 kroner venter vinner-prosjektet, og alt du trenger å gjøre er å fortelle oss hvorfor akkurat ditt prosjekt bør vinne Helseprisen. Du kan nominere så mange prosjekter du vil, og alle som ønsker kan nominere.

   Fristen for å nominere er 10. september 2024.

Les mer og nominer https://dam.no/2024/06/05/na-er-vi-pa-jakt-etter-norges-beste-helseprosjekt/

NCU provides funding to support and stimulate collaborative cancer research within the Nordic countries. The main focus of NCU funded research is «clinical epidemiology».

The application deadline is extended to Monday 16th of September at 16.00.

https://ncu.nu/cancer-research/application/